will find three things we at CardioSound can do for patients with atherosclerotic disease:
measure it, monitor it, or manage it.
You decide what you want.
How much risk does my patient carry?
Initial risk assessment with lDL treatment analysis
We measure the extent of atherosclerosis and evaluate genetic markers to assess a patient's CV event risk. Because the testing we provide is not covered by the health insurance industry, the cost of this service is an out-of-pocket expense. Referring physicians receive a report for the patient medical record, and if needed, a letter for the insurance company.
ask the arteries trending program
As important as bio-markers like LDL are, monitoring blood test results can give a false sense of security. Monitoring end-organ damage (arterial plaque) is a more powerful way to know how the disease is responding to treatment. In high risk patients, our disease monitoring program Ask the Arteries takes the guess work out of clinical management. How aggressive should the treatment program be? Let the arteries tell you. Is the treatment program working or not? The arteries will tell you.
Because this service is not covered by the health insurance industry, the cost is out-of-pocket for patients.
medication management program
For patients who cannot tolerate statins, and for people with genetically high cholesterol, our LDL management program gets patients to their genetically-defined LDL target, Being a diplomate of the American Board of Clinical Lipidology, Dr. Hight has experience getting insurance approval for the more expensive PCSK-9 inhibitors.
Critical care, our 1st year risk factor management path
Designed for the patient with the highest risk of events, our Critical Care program offers the most aggressive risk factor management treatment available. Dr. Hight uses the Bale-Doneen method together with the Ask the Arteries ultrasound trending program he developed.
Who has the highest risk? Recent heart attack survivors have the highest death rate.
Isn't Dr. HIght a primary care physician? How do I know he won't keep my primary care patients?
Dr. Hight, a diplomate of the American Board of Lipidology, closed his primary care practice (Towne Lake Internal Medicine) as of Aug 16, 2017.
What if, after a year of being on medication, more documentation becomes necessary in order to justify the ongoing need for aggressive pharmacological therapy?
Our Ask the Arteries program, if needed, can be used as a basis for making the case for ongoing aggressive therapy. We handle all the documentation necessary to keep patients on life-saving medications.